• Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway

    3 monthes ago - By Fierce Biotech

    Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway ntaylor
    Tue, 06/29/2021 - 08:06
    Read more ...